Most fibromyalgia patients randomized to continuing milnacipran (Savella) at the end of a clinical trial never noticed an increase in pain. Patients in the placebo group had quite a different experience.
(AUDIO) A new paradigm in pain research provides simple ways to identify patients with disorders like arthritis or lupus who won't respond to standard treatments. Pain expert Daniel Clauw MD gives the details in this podcast.
(AUDIO) What can you do when the recommended medications for fibromyalgia aren’t working? Listen to Chad Boomershine MD describe the advantages and complexities of combination drug therapy for this condition.